Evidence map›Paper›PMID 38542769›Full record

Observational studyNutrients2024

Effect of Donated Premature Milk in the Prevention of Bronchopulmonary Dysplasia.

Amaia Merino-Hernández, Andrea Palacios-Bermejo, Cristina Ramos-Navarro, Silvia Caballero-Martín, Noelia González-Pacheco, Elena Rodríguez-Corrales, María Carmen Sánchez-Gómez de Orgaz, Manuel Sánchez-Luna

Abstract readObservational Study
In one paragraph

Observational study in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amaia Merino-HernándezNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.ORCID 0000-0002-5121-8291
Andrea Palacios-BermejoNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Cristina Ramos-NavarroNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.ORCID 0000-0002-6693-6405
Silvia Caballero-MartínNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Noelia González-PachecoNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Elena Rodríguez-CorralesNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
María Carmen Sánchez-Gómez de OrgazNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Manuel Sánchez-LunaNeonatology Division, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.ORCID 0000-0001-9543-7392

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBreastfeeding is one of the strategies that has been shown to be effective in preventing severe forms of bronchopulmonary dysplasia (BPD). When mother's own milk (MOM) is not available, pasteurized donor milk (DM) is the best alternative. However, the evidence is inconclusive on the difference in the incidence of bronchopulmonary dysplasia (BPD) between patients fed MOM and those fed with DM. As standard DM is usually mature pooled milk donated by mothers who have delivered their babies at term, the potential benefits of preterm milk may be lost. MATERIALS AND

methodsAn observational, retrospective, single-center study was conducted in the neonatology department of a high-complexity hospital. The study included newborns <32 weeks of gestational age born between January 2020 and December 2022. When supplemental milk was needed, non-pooled preterm pasteurized donor milk (PDM) matched for gestational age and moment of lactation was used in this study, classifying preterm infants in two groups: mainly MOM (>50% of the milk) or mainly PDM (>50% of the milk). Two groups were established: those who received >50% MOM and those who received >50% PDM. They were also classified according to the diagnosis of DBP: one group included no BPD or grade 1 BPD (noBPD/1), while the other included grade 2 or 3 BPD (BPD 2-3). The objectives of this study were, firstly, to evaluate the incidence of BPD 2-3 among patients who predominantly received PDM versus MOM. Secondly, to analyze differences in the type of human milk received and its nutritional components, as well as to study the growth in patients with or without BPD.

resultsOne hundred ninety-nine patients were included in the study. A comparison of noBPD/1 versus BPD 2-3 groups between those receiving mainly MOM versus PDM showed no significant differences (19% vs. 20%,

conclusionsThe use of mainly MOM or PDM demonstrates a similar incidence of noBPD/1 or BPD 2-3. Non-pooled and matched by gestational age and time of lactation preterm donor milk can probably be an alternative when mother's own milk is not available, with a similar protective effect in the prevention of severe BPD.

Indexed as

Bronchopulmonary DysplasiaPremature BirthBreast FeedingFemaleHumansInfantInfant, NewbornInfant, PrematureInfant, Very Low Birth WeightMilk, HumanRetrospective Studiesbronchopulmonary dysplasiamother’s own milkpasteurized donor milk

Identifiers

PMID38542769
PMCPMC10974788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.